European Union - English - EMA (European Medicines Agency)

smithkline beecham ltd - rosiglitazone, glimepiride - diabetes mellitus, type 2 - drugs used in diabetes - avaglim is indicated in the treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glycaemic control on optimal dosage of sulphonylurea monotherapy, and for whom metformin is inappropriate because of contraindication or intolerance.

European Union - English - EMA (European Medicines Agency)

smithkline beecham plc - rosiglitazone, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - avandamet is indicated in the treatment of type 2 diabetes mellitus patients, particularly overweight patients:who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone.in triple oral therapy with sulphonylurea in patients with insufficient glycaemic control despite dual oral therapy with their maximally tolerated dose of metformin and a sulphonylurea (see section 4.4).

European Union - English - EMA (European Medicines Agency)

smithkline beecham plc - rosiglitazone - diabetes mellitus, type 2 - drugs used in diabetes - rosiglitazone is indicated in the treatment of type 2 diabetes mellitus:as monotherapy-in patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intoleranceas dual oral therapy in combination with-metformin, in patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin-a sulphonylurea, only in patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite monotherapy with a sulphonylureaas triple oral therapy in combination with-metformin and a sulphonylurea, in patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy (see section 4.4).

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - mupirocin calcium eqv mupirocin - cream - 2% w/w - mupirocin calcium eqv mupirocin 2% w/w

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin trihydrate 229.58mg/5ml eqv amoxycillin; potassium clavulanate 33.95mg/5ml eqv clavulanic acid - powder, for suspension - 200 mg/5 ml - amoxycillin trihydrate 229.58mg/5ml eqv amoxycillin 200 mg/5 ml; potassium clavulanate 33.95mg/5ml eqv clavulanic acid 28.5 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin trihydrate 459.17mg/5ml eqv amoxycillin; potassium clavulanate 67.9mg/5ml eqv clavulanic acid - powder, for suspension - 400 mg/5 ml - amoxycillin trihydrate 459.17mg/5ml eqv amoxycillin 400 mg/5 ml; potassium clavulanate 67.9mg/5ml eqv clavulanic acid 57 mg/5 ml

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin trihydrate eqv amoxycillin; potassium clavulanate eqv clavulanic acid - tablet, film coated - 500 mg - amoxycillin trihydrate eqv amoxycillin 500 mg; potassium clavulanate eqv clavulanic acid 125 mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin trihydrate 1004.43mg eqv amoxycillin; potassium clavulanate 148.91mg eqv clavulanic acid - tablet, film coated - 875 mg - amoxycillin trihydrate 1004.43mg eqv amoxycillin 875 mg; potassium clavulanate 148.91mg eqv clavulanic acid 125 mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin sodium 1060.18 mg eqv. to amoxicillin free acid; potassium clavulanate 238.25 mg eqv. to clavulanic acid - injection, powder, for solution - 1 g/vial - amoxycillin sodium 1060.18 mg eqv. to amoxicillin free acid 1000 mg/vial; potassium clavulanate 238.25 mg eqv. to clavulanic acid 200 mg/vial

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - amoxycillin sodium 530.09 mg eqv. to amoxicillin free acid; potassium clavulanate 119.13 mg eqv. to clavulanic acid - injection, powder, for solution - 500 mg/vial - amoxycillin sodium 530.09 mg eqv. to amoxicillin free acid 500 mg/vial; potassium clavulanate 119.13 mg eqv. to clavulanic acid 100 mg/vial